3 курс / Фармакология / Диссертация_Горбунова_Ю_В_Психотропная_и_нейропротективная_активность

181

150.Smith, H.O. Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group / H.O. Smith, J.A. Blessing, L. Vaccarello // Gynecol. Oncol. - 2002. - Vol. 84, № 1. - P. 140-144.

151.Somer, F. Original 2-alkylamino-6-halogenoquinazolin-4 (3H)-ones and К (ATP) channel activity / F. Somer // J. Med. Chem. - 2001. - Vol. 44, № 16. - P. 2575-2585.

152.Speck-Planche, A. Multi-target drug discovery in medicinal chemistry: current status and future perspectives / A. Speck-Planche, M.N. Cordeiro // Mini-Reviews in Medicinal Chemistry. – 2015. - №15(8). – Р. 606-607.

153.Tazarki, H. New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. / H. Tazarki, W. Zeinyeh, Y.J. Esvan, S. Knapp, at al. // Eur J Med Chem. – 2019. Mar, 15. Vol. 166. – P. 304-317.

154.Tobe, M. Structure-activity relationships of 6-nitroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation / M. Tobe, Y. Isobe, H. Tomizawa [et al.] // Chem. Pharm. Bull. - 2002. -

Vol. 50, № 8. - P. 1073-1080.

155.Vijaychand, A. Medicinal and biological significance of quinazoline: a highly important scaffold for drug discovery: a review / Vijaychand A. // Int. J. Pharm. Bio. Sci. - 2011. - Vol. 2, № 1. - P. 780-809.

156.Vizgunova, O.L. Study in the series of 4-quinazolinones. XVII. Synthesis and biological activity of 1,2-disubstituted 4-quinazolinones / Vizgunova O.L. // Pharm. Chem. J. - 1987. - Vol. 20, № 9. - P. 614-617.

157.Wang, T. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease / T. Wang, X.H. Liu, J. Guan [et. al.] // European Journal of Medicinal Chemistry. - 2019. - №1. – Р. 200-223.

158.Wanleenuwat, P. Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline / P. Wanleenuwat, P. Iwanowski, W. Kozubski // Postgraduate Medicine. – 2019. - №131(7). – Р. 415-422.

182

159.Wei, D. Synthesis and anti-tumor activity of [1,4] dioxino [2,3-f] quinazoline derivatives as dual inhibitors of c-Met and VEGFR-2 / D. Wei, H. Fan, K. Zheng, X. Qin at al. // Bioorg Chem. – 2019. Vol. 88. – P. 102916.

160.Wolak, T. Doxazosin to treat hypertension: it's time to take it personally--a

retrospective analysis of 19, 495 patients / T. Wolak, R. Toledano, V. Novack [et al.] // J

Hypertens. – 2014. – Vol. 32, № 5. – P. 1132-1137.

161.Wolfe, J.F. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-

4(3H)-quinazolinones / J.F. Wolfe, T.I. Rathman, M.C. Sleevi // J. Med. Chem. - 1990. - Vol. 33. - P. 161-166.

162.Writer, B.W. Prazosin for military combat-related PTSD nightmares: a critical review / B.W. Writer, E.G. Meyer, J.E. Schillerstrom // J Neuropsychiatry Clin Neurosci.

– 2014. – Vol. 26, № 1. – P. 24-33.

163. Wu, K.J. A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain. / K.J. Wu, S.J. Yu, K.S. Shia [et al.] // Cell Transplant. – 2017. Apr 13, Vol. 26,

№4. – P. 571-583.

164.Wu, Y. Optimization of combinations of ginsenoside-Rg1, ginsenoside-Rb1, evodiamine and rutaecarpine for effective therapy of mouse migraine / Y. Wu, X. Pan, Y. Xu [et al.] // J Nat Med. – 2016. – Vol. 70, № 2. – P. 207-216.

165.Xie, N. A selective inhibitor of Drp1, mdivi-1, protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats / N. Xie, C. Wang, Y. Lian [et al.] // Neurosci Lett. - 2013. - Vol. 545. - P. 64-68.

166.Zhang, H.J. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl- [1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives / H.J. Zhang, P. Jin, S.B. Wang [et. al.] // Arch Pharm (Weinheim). – 2015. - №348(8). - Р. 564-574.

167.Zhang, H.J. Synthesis and antidepressant activities of 4-(substituted- phenyl)tetrazolo[1,5-a]quinazolin-5(4H)-ones and their derivatives / H.J. Zhang, S.B. Wang, Z.S. Quan // Mol Divers. – 2015. - №19(4). – Р. 817-828.

168.Zhang, K. Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases

183

and Histone Deacetylases / K. Zhang, F. Lai, S. Lin at al. // J Med Chem. – 2019. - Vol.

62. №15. - P. 6992-7014.

169.Zhang, L. A newly designed intensive caregiver education program reduces cognitive impairment, anxiety, and depression in patients with acute ischemic stroke / L. Zhang, T. Zhang, Y. Sun // Brazilian Journal of Medical and Biological Research. – 2019. - №52(9). – Р.8533.

170.Zuo, S.J. Discovery of novel 3-benzylquinazolin-4(3H)-ones as potent vasodilative agents / S.J. Zuo, S. Li, R.H. Yu [et. al.] // Bioorg Med Chem Lett. – 2014. - №15. – Р. 5597-5601.